GeneOne Life Science, Inc.

A011000

KR7011000007

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
2,375 ^KRW	-0.42%		+0.21%	-16.37%

Mar. 28	GeneOne Life Science, Inc. announced that it has received KRW 3.6000014 billion in funding	CI
Mar. 27	GeneOne Life Science, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

GeneOne Life Science, Inc. announced that it has received KRW 2.46998556 billion in funding

September 14, 2023

On September 15, 2023, GeneOne Life Science, Inc. closed the transaction.

Latest news about GeneOne Life Science, Inc.

GeneOne Life Science, Inc. announced that it has received KRW 3.6000014 billion in funding	Mar. 27	CI
GeneOne Life Science, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 27	CI
GeneOne Life Science, Inc. announced that it expects to receive KRW 3.6000014 billion in funding	Mar. 20	CI
GeneOne Life Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
GeneOne Life Science, Inc. announced that it has received KRW 2.46998556 billion in funding	23-09-14	CI
Gene One Life Science to Raise 2.5 Billion Won via Stock Sale	23-09-06	MT
GeneOne Life Science, Inc. announced that it expects to receive KRW 2.46998556 billion in funding	23-09-05	CI
GeneOne Life Science, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Gene One Life Science to Raise 80 Billion Won via Share Sale	23-05-17	MT
GeneOne Life Science, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
GeneOne Life Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
GeneOne Life Science, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-16	CI
GeneOne Life Science, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
GeneOne Life Science, Inc. announced that it has received KRW 11.7 billion in funding	22-04-14	CI
GeneOne Life Science, Inc. announced that it expects to receive KRW 11.7 billion in funding	22-04-12	CI
GeneOne Life Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-08	CI
SK bioscience : S.Korea to begin producing Novavax COVID-19 vaccine as early as June	21-04-12	RE
GeneOne Life Science, Inc. announced that it has received KRW 24 billion in funding from a group of investors	20-11-24	CI
GeneOne Life Science, Inc. announced that it expects to receive KRW 24 billion in funding from a group of investors	20-11-22	CI
VGX Pharmaceuticals, Inc. Terminates CELLECTRA Device License Agreement with GeneOne	20-10-15	CI
GeneOne Life Science, Inc.(KOSE:A011000) added to S&P Global BMI Index	20-09-21	CI
INOVIO and GeneOne Life Science Report Positive Phase 1/2a Clinical Data with DNA Vaccine INO-4700 for MERS Coronavirus a the American Society of Gene & Cell Therapy Conference	20-04-28	CI
GeneOne Life Science, Inc.(KOSE:A011000) dropped from S&P Global BMI Index	19-09-23	CI
GeneOne Life Science, Inc. announced that it has received KRW 2.95000061 billion in funding	19-07-07	CI
GeneOne Life Science, Inc. announced that it expects to receive KRW 2.95000061 billion in funding	19-06-30	CI

Chart GeneOne Life Science, Inc.

Duration

Period

More charts

GeneOneLifeScience, formerly VGX International, Inc., is a Korea-based company engaged in textile and biopharmaceutical businesses. The Company is a biomedical contract manufacturing organization (CMO). Its textile business engages in the provision of wicks under the brand name of INTERON, which are used in dress shirts, suits and caps. Its biopharmaceutical business engages in the research, development and manufacture of biomedical, plasmid deoxyribonucleic acid (DNA) and DNA vaccines. It also engaged in the leasing of nonresidential buildings.

Sector

Biotechnology & Medical Research

Calendar

2024-05-12 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
GENEONE LIFE SCIENCE, INC.	-16.37%	138M
IQVIA HOLDINGS INC.	+2.07%	42.75B
LONZA GROUP AG	+47.87%	41.61B
MODERNA, INC.	+12.18%	41.34B
CELLTRION, INC.	-12.36%	26.59B
ICON PUBLIC LIMITED COMPANY	+8.03%	25.49B
ALNYLAM PHARMACEUTICALS, INC.	-23.72%	18.12B
MEDPACE HOLDINGS, INC.	+30.13%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.77%	11.76B
UNITED THERAPEUTICS CORPORATION	+8.10%	11B